Home
Sucampo Pharmaceuticals

Sucampo Pharmaceuticals Market Share Analysis for May 2026

An essential part of our mission is to improve lives. So we’re shining a spotlight on a few of our patients and their families inspiring stories.

Health > Biotechnology and Pharmaceuticals

Domainsucampo.com

Year Founded1996

Employees51 - 200

Annual Revenue$200M - $500M

Sucampo Pharmaceuticals

Sucampo Pharmaceuticals (including company regionals)

sucampo.com

See more website traffic and engagement information

Sucampo Pharmaceuticals Revenue up to May 2026 is 200M - 500M

revenue generated by Sucampo Pharmaceuticals top domains

Sucampo Pharmaceuticals top domains revenue over 3 years

Revenue for Sucampo Pharmaceuticals top domains

sucampo.com200M - 500M

See more with Sales Intelligence

Total visits to Sucampo Pharmaceuticals's top domains

Understand Sucampo Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Sucampo Pharmaceuticals's top domains

Analyze Sucampo Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Sucampo Pharmaceuticals's top domains

See how Sucampo Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Sucampo Pharmaceuticals top competitors by domain

Top similar sites in May 2026, ranked by their affinity

shionogi.comCompany NameShionogi & Co., Ltd.Employees1001 - 5000HQJapan, osakaAnnual revenue> $1BTotal visits539.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sucampo Pharmaceuticals

These are the website technologies, by industry, used by Sucampo Pharmaceuticals top domains

Advertising (2)

LinkedIn Advertiser

Audio Video Media (2)

Vimeo

Email Services (2)

Microsoft Exchange Online

Widget (2)

Twemoji

More Technologies

7

See all

News & Signals from Sucampo Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSucampo Pharmaceuticals, Inc. partnered with Takeda Pharmaceuticals on Jul 1st '06.The case centered on Amitiza, a medication developed by Sucampo Pharmaceuticals, which partnered with Takeda to market the drug in the United States after its approval in 2006.

NewsTakeda Pharmaceuticals ended partnership with Sucampo Pharmaceuticals, Inc. on Mar 31st '24.Takeda's collaboration and license agreement with Sucampo related to AMITIZA was terminated as of March 31, 2024, and Takeda no longer sells or markets AMITIZA.

NewsSucampo Pharmaceuticals, Inc. partnered with Dr. Reddy’s Laboratories Ltd. on Jan 20th '21.The Sucampo Pharmaceuticals, Inc. also partnered with Par Pharmaceuticals, Inc. and Dr. Reddy’s Laboratories Ltd.